MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MESO
  4. News
MESO
Quote
Short
News
Articles
Message Board

Mesoblast Limited (NASDAQ : MESO ) News

Mesoblast Limited (NASDAQ: MESO) News Releases

MESO News Releases
MESO : NASDAQ
Canada Newswire
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
MESO : NASDAQ
SeekingAlpha
Mesoblast reports Q1 results
MESO : NASDAQ
GlobeNewswire
Mesoblast Reports Ryoncil® Net Revenues of US$30.3m and Improved Net Operating Cash Spend for the Quarter to US$4.1 Million
MESO : NASDAQ
GlobeNewswire
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
MESO : NASDAQ
SeekingAlpha
Mesoblast gains on licensing deal for CAR technology platform
MESO : NASDAQ
GlobeNewswire
Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
MESO : NASDAQ
SeekingAlpha
Mesoblast Limited: A Risk/Reward Story
MESO : NASDAQ
GlobeNewswire
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
MESO : NASDAQ
SeekingAlpha
Mesoblast Limited (MESO) Discusses Cellular Medicine Platforms and Innovations at R&D Day Transcript
MESO : NASDAQ
SeekingAlpha
Why Mesoblast's Move Into DMD Warrants A Speculative Buy (Upgrade)
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.